http://www.medicalnewstoday.com/medical ... wsid=60833
LX211 is in clinical trials for non infectious uveitis. it would be the FIRST drug approved for treatment of uveitis if it succeeds.
LX201 is for corneal transpant rejection and is an implanted device
LX211 and LX201 for uveitis and corneal transplant rejectio
Moderators: Mike Bartolatz, kwork
-
- Posts: 6595
- Joined: Fri Feb 06, 2004 9:58 pm
LX211 and LX201 for uveitis and corneal transplant rejectio
Mike Bartolatz
Moderator
Moderator
-
- Posts: 6595
- Joined: Fri Feb 06, 2004 9:58 pm
http://clinicaltrials.gov/show/NCT00404742
phase III trials underway on LX211
trials of LX201 expected end of 1st quarter 2007
phase III trials underway on LX211
trials of LX201 expected end of 1st quarter 2007
Mike Bartolatz
Moderator
Moderator
-
- Posts: 6595
- Joined: Fri Feb 06, 2004 9:58 pm
Re: LX211 and LX201 for uveitis and corneal transplant rejectio
http://micro.newswire.ca/release.cgi?rk ... rt=0&htm=0
it could be quiet some time before Luveniq is approved for uveitis. the FDA has requested an additional trial be done for safety of Voclosporine in the treatment of intermediate and posterior uveitis.
it could be quiet some time before Luveniq is approved for uveitis. the FDA has requested an additional trial be done for safety of Voclosporine in the treatment of intermediate and posterior uveitis.
Mike Bartolatz
Moderator
Moderator